Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ)
CNY 6.63
(0.45%)
CNY 6.63
(0.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 382.66 Million | 376.41 Million | 126.07 Million | 250.64 Million | 334.08 Million | 262.36 Million |
| Net Income | 326.89 Million | 190.08 Million | 140.11 Million | 106.12 Million | 250.98 Million | 226.81 Million |
| Depreciation & Amortization | 37.53 Million | 31.7 Million | 33.85 Million | 40.8 Million | 48.08 Million | 47.84 Million |
| Deferred income taxes | -7.52 Million | -3.25 Million | 2.58 Million | -6.6 Million | -3.03 Million | -4.81 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 21.49 Million | 136.01 Million | -49.45 Million | 103.79 Million | 32.88 Million | -54.87 Million |
| Other non-cash items | 110.69 Thousand | 18.6 Million | 1.56 Million | -82.39 Thousand | 2.12 Million | 42.57 Million |
| Investing Cash Flow | -198.63 Million | -285.37 Million | -83.5 Million | 65.21 Million | -600.75 Million | -174.04 Million |
| Investments in PPE | -29.07 Million | -31.61 Million | -42.54 Million | -13.93 Million | -15.45 Million | -26.07 Million |
| Acquisitions | 28.81 Thousand | 269 Thousand | -14.52 Million | -4.45 Million | 75.9 Thousand | - |
| Investment purchases | -1.97 Billion | -1.65 Billion | -2.35 Billion | -1.78 Billion | -1.17 Billion | -260.27 Million |
| Sales/Maturities of investments | 1.97 Billion | 1.7 Billion | 2.39 Billion | 2.12 Billion | 1.33 Billion | 321.96 Million |
| Other Investing Activities | -168.98 Million | -302.99 Million | -64.51 Million | -251.12 Million | -752.97 Million | -209.65 Million |
| Financing Cash Flow | -62.76 Million | -52.3 Million | -69.36 Million | -69.39 Million | -223.83 Million | -123.27 Million |
| Debt repayment | - | - | -37.72 Million | -35.72 Million | - | -16 Million |
| Dividends payments | -62.76 Million | -52.3 Million | -31.38 Million | -104.6 Million | -106.41 Million | -107.14 Million |
| Common Stock Repurchased | - | - | - | - | -117.41 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -264.7 Thousand | 71.44 Million | -0.54 | -120.78 Thousand |
| Accounts receivables | 99.52 Million | 58.31 Million | -74.89 Million | 137.88 Million | 57.45 Million | -22.89 Million |
| Accounts payables | -60.17 Million | 76.9 Million | -4.37 Million | -25.24 Million | -4.06 Million | -35.73 Million |
| Inventory | -10.33 Million | 4.05 Million | 27.22 Million | -2.22 Million | -17.46 Million | 8.56 Million |
| Other working capital | -5.32 Million | -3.25 Million | 2.58 Million | -6.6 Million | -3.03 Million | -63.44 Million |
| Cash at beginning of period | 314.48 Million | 275.73 Million | 302.53 Million | 56.06 Million | 546.56 Million | 581.51 Million |
| Cash at end of period | 435.75 Million | 314.48 Million | 275.73 Million | 302.53 Million | 56.06 Million | 546.56 Million |
| Capital Expenditure | -29.07 Million | -31.61 Million | -42.54 Million | -13.93 Million | -15.45 Million | -26.07 Million |
| Effect of forex changes on cash | - | - | - | - | - | 0.99 |
| Net cash flow / Change in cash | 121.27 Million | 38.74 Million | -26.79 Million | 246.47 Million | -490.5 Million | -34.95 Million |
| Free Cash Flow | 353.58 Million | 344.8 Million | 83.53 Million | 236.71 Million | 318.62 Million | 236.29 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 74.92 Million | 53.68 Million | 88.45 Million | 131.74 Million | 326.89 Million | 60.83 Million |
| Depreciation & Amortization | - | 8.97 Million | 8.97 Million | 37.53 Million | 37.53 Million | -17.56 Million |
| Deferred income taxes | - | - | - | - | -7.52 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 166.82 Million | - | 83.87 Million | 21.49 Million | 154.95 Million |
| Other non-cash items | 55.75 Million | 13.93 Million | -15.51 Million | -160.43 Million | 110.69 Thousand | -86.52 Million |
| Investing Cash Flow | 1.41 Million | -147.66 Million | 29.8 Million | -194.22 Million | -198.63 Million | -117.61 Million |
| Investments in PPE | -592.58 Thousand | -136.14 Million | -957.97 Thousand | -12.43 Million | -29.07 Million | -1.66 Million |
| Acquisitions | - | - | 884.96 | 28.81 Thousand | 28.81 Thousand | - |
| Investment purchases | -357.8 Million | -114.9 Million | -526.48 Million | -591.47 Million | -1.97 Billion | -483.57 Million |
| Sales/Maturities of investments | 359.82 Million | 103.4 Million | 557.23 Million | 612.38 Million | 1.97 Billion | 354.09 Million |
| Other Investing Activities | -10 Thousand | -20 Thousand | 20 Thousand | -202.72 Million | -168.98 Million | 13.53 Million |
| Financing Cash Flow | 2.97 Million | -104.6 Million | - | - | -62.76 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -14.7 Thousand | -104.6 Million | - | - | -62.76 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 2.99 Million | -104.6 Million | - | - | - | - |
| Accounts receivables | - | 150.97 Million | - | 99.52 Million | 99.52 Million | 158 Million |
| Accounts payables | - | - | - | - | -60.17 Million | - |
| Inventory | - | 20.07 Million | - | -10.33 Million | -10.33 Million | -3.04 Million |
| Other working capital | - | -4.23 Million | - | -5.32 Million | -5.32 Million | - |
| Cash at beginning of period | 344.36 Million | 538.5 Million | 435.75 Million | 537.26 Million | 314.48 Million | 544.08 Million |
| Cash at end of period | 476.87 Million | 344.36 Million | 538.5 Million | 435.75 Million | 435.75 Million | 537.26 Million |
| Capital Expenditure | -592.58 Thousand | -136.14 Million | -957.97 Thousand | -12.43 Million | -29.07 Million | -1.66 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 132.5 Million | -194.13 Million | 102.75 Million | -101.51 Million | 121.27 Million | -6.81 Million |
| Free Cash Flow | 130.09 Million | -77.51 Million | 71.98 Million | 80.28 Million | 353.58 Million | 110.04 Million |
AMPLI
0467
0IC7
EXCL
MUR
EMCGU